This inventor holds 1 USPTO granted patent. Top assignee: Global Alliance for Tb Drug Development. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Dongfeng Zhang
Introduction
Dongfeng Zhang is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of antimicrobial therapy through his innovative research and development. His work focuses on novel oxazolidinones, which have the potential to treat various microbial infections.
Latest Patents
Dongfeng Zhang holds a patent for "Substituted phenyloxazolidinones for antimicrobial therapy." This invention relates to novel oxazolidinones characterized by N-containing monocyclic, bicyclic, or spirocyclic substituents. The patent outlines their preparation and use as drugs for treating microbial infections, either alone or in combination with other anti-infective treatments. He has 1 patent to his name.
Career Highlights
Dongfeng Zhang is associated with the Global Alliance for TB Drug Development, where he applies his expertise to advance research in tuberculosis treatment. His work is crucial in the ongoing battle against infectious diseases, particularly in developing effective therapies.
Collaborations
Throughout his career, Dongfeng Zhang has collaborated with notable colleagues, including Christopher Blair Cooper and Haihong Huang. These partnerships have enhanced the scope and impact of his research.
Conclusion
Dongfeng Zhang's innovative work in antimicrobial therapy exemplifies the importance of research and development in combating infectious diseases. His contributions continue to pave the way for new treatment options and improve public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile